✦ LIBER ✦
Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome
✍ Scribed by Sophie Dimicoli; Elias Jabbour; Gautam Borthakur; Tapan Kadia; Zeev Estrov; Hui Yang; Mary Kelly; Sherry Pierce; Hagop Kantarjian; Guillermo Garcia-Manero
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 850 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.